Mubasher TV
Contact Us Advertising   العربية

Julphar turns to losses in Q2-19

Julphar turns to losses in Q2-19
Julphar’s losses amounted to AED 89.1 million in Q1-19
Julphar
JULPHAR
-1.04% 0.95 -0.01

Abu Dhabi – Mubasher: Gulf Pharmaceutical Industries Company (Julphar) has suffered losses during the second quarter of 2019, against profits achieved in the corresponding period last year.

The company incurred losses attributed to the owners of the parent company worth AED 94.8 million, against AED 31.3 million profits in Q2-18, Julphar disclosed to the Abu Dhabi Securities Exchange (ADX) on Wednesday.

In the first half of 2019, the company suffered losses of AED 183.9 million, versus profits of AED 50.9 million in H1-18.

Sales declined to AED 557.6 million in H1-19 from AED 218.4 million in H1-18.

It is worth noting that in the first quarter of 2019, Julphar’s losses amounted to AED 89.1 million, when compared to profits of AED 19.6 million in Q1-18.